This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

LipiGesic™ M Is Recognized By Headache Experts As An Excellent First-Line Therapy For Acute Migraine Treatment

SCHOFIELD, Wis., Nov. 13, 2012 /PRNewswire/ -- PuraMed BioScience ®, Inc,. (OTCQB: PMBS) announces that its homeopathic migraine formulation, LipiGesic® M, has been recognized as an excellent first-line therapy in the treatment of acute migraine. The declaration was made in the online article " Advances in Drug Development for Acute Migraine ," [page 14] scheduled for publication in an upcoming printed issue of Drugs, a medical journal evaluating drugs and drug therapies read by over 500,000 healthcare providers.

Authors Ryan J. Cady, Candace L. Shade, and Roger K. Cady, MD, reviewed 11 drugs, which are considered advancements in acute migraine treatment. LipiGesic M was the only product described as "an excellent first-line therapy for very early intervention, as it is compatible with all other acute treatment options."

"With this ' excellent first-line therapy' designation, consumers can be assured that headache experts have reviewed the clinical study evidence for LipiGesic M's efficacy and have determined that LipiGesic M is the first medication sufferers should take to relieve migraine pain and migraine associated symptoms," said Russell Mitchell, president and CEO of PuraMed BioScience.

LipiGesic M is an over-the-counter, homeopathic formulation of feverfew and ginger delivered in a sublingual (under-the-tongue) gel for the acute treatment of migraine. Sublingual delivery preserves the effectiveness of the active ingredients since they are absorbed directly into the blood stream bypassing the digestive system where breakdown occurs.

"Migraine sufferers are looking for relief, but many current treatments produce severe and often debilitating side effects," said Mitchell. "Our non-drowsy formulation can relieve migraine headaches without medication hangover symptoms at a fourth of the cost of the top-selling prescription treatments. Inclusion in the article as the only over-the-counter product in the advancement of acute migraine treatment with the advantages of lower cost and little to no risk of medication overuse or rebound headaches is encouraging.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.27 -0.76%
FB $101.00 1.47%
GOOG $684.12 0.89%
TSLA $143.67 -3.09%
YHOO $27.10 1.04%


Chart of I:DJI
DOW 15,914.74 -99.64 -0.62%
S&P 500 1,851.86 -0.35 -0.02%
NASDAQ 4,283.5920 +14.8290 0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs